Hanwha
HANWHA CORPORATION

[Class - 1]

METALSILICONES; POLYSILICONES; CARBON NANOTUBES; PROCESSED CARBON NANOTUBES; FUNCTIONALIZED CARBON NANOTUBES; CARBON NANOTUBES IN UNPROCESSED OR PURIFIED FORMS, AND AFTER TREATMENT OR TRANSFORMATION FOLLOWING THEIR SYNTHESIS; CARBON NANOTUBE COMPOSITES; ORGANIC COMPOSITIONS MADE OF CARBON NANOTUBES; PLASTICS CONSISTING OF OR INCORPORATING CARBON NANOTUBES; POLYMERS AND POLYMER ADDITIVES CONSISTING OF OR INCORPORATING CARBON NANOTUBES; SILICONE CONSISTING OF OR INCORPORATING CARBON NANOTUBES; INKS CONSISTING OF OR INCORPORATING CARBON NANOTUBES; COMPOSITE MATERIALS AND CHEMICALS CONSISTING OF OR INCORPORATING CARBON NANOTUBES FOR FIRE PROTECTION AND FLAME PROTECTION PURPOSES; CHEMICAL ADDITIVES, FOR ENHANCING CONDUCTIVITY, INCLUDING ELECTRIC AND THERMAL; CHEMICAL ADDITIVES FOR PREPARING CERAMIC AND METALLIC ALLOYS; IRON OXIDE; MANGANO-MANGANIC OXIDE; DISPERSIONS (DISPERSIONS IIQUID)OF SILVER, COPPER OR NICKEL; SILVER NANOPARTICLES, COPPER NANOPARTICLES, NICKEL NANOPARTICLES

[Class - 5]

BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES; ANTI-CANCER PREPARATIONS; PHARMACEUTICALS FOR THE TREATMENT OF IMMUNE DISEASES; PHARMACEUTICAL PREPARATIONS FOR HUMAN USE; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF BREAST CANCER; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF ARTHRITIS;